35088915|t|A novel DPP-4 inhibitor Gramcyclin A attenuates cognitive deficits in APP/PS1/tau triple transgenic mice via enhancing brain GLP-1-dependent glucose uptake.
35088915|a|Enhancing glucagon-like peptide 1 (GLP-1) signaling with a dipeptidyl peptidase IV (DPP-4) inhibitor might exert protective effects on Alzheimer's disease (AD). We found that intragastric administration of Gramcyclin A (10, 20 and 40 mg/kg), a novel DPP-4 inhibitor, for 3 months significantly reversed cognitive decline in APP/PS1/tau triple transgenic mice in a dose-dependent manner. Gramcyclin A treatment markedly reduced Abeta plaques as well as the insoluble and soluble forms of Abeta40 and Abeta42 in the hippocampus of APP/PS1/tau mice. Treatment with Gramcyclin A remarkedly decreased the level of microglia and suppressed neuroinflammation in the hippocampus of APP/PS1/tau mice. Moreover, Gramcyclin A treatment could increase brain glucose uptake in APP/PS1/tau mice, as detected by 18-fluoro-2-deoxyglucose (18 F-FDG) micro-positron emission tomography (micro-PET) imaging. Furthermore, Gramcyclin A significantly increased expression of glucagon-like peptide-1 (GLP-1), GLP-1R, proliferator-activated receptor gamma coactivator (PGC)-1alpha and glucose transporter 4 (GLUT4), and inhibited insulin receptor (IRS)-1 phosphorylation and tau hyperphosphorylation in the hippocampus of APP/PS1/tau mice. Collectively, Gramcyclin A conferred protective effects against AD via enhancing brain GLP-1-dependent glucose uptake. The DPP-4 inhibitor Gramcyclin A might be a potential therapeutic drug for AD.
35088915	8	13	DPP-4	Gene	13482
35088915	24	36	Gramcyclin A	Chemical	-
35088915	48	66	cognitive deficits	Disease	MESH:D003072
35088915	74	77	PS1	Gene	19164
35088915	100	104	mice	Species	10090
35088915	125	130	GLP-1	Gene	14526
35088915	141	148	glucose	Chemical	MESH:D005947
35088915	192	197	GLP-1	Gene	14526
35088915	216	239	dipeptidyl peptidase IV	Gene	13482
35088915	241	246	DPP-4	Gene	13482
35088915	292	311	Alzheimer's disease	Disease	MESH:D000544
35088915	313	315	AD	Disease	MESH:D000544
35088915	363	375	Gramcyclin A	Chemical	-
35088915	407	412	DPP-4	Gene	13482
35088915	460	477	cognitive decline	Disease	MESH:D003072
35088915	485	488	PS1	Gene	19164
35088915	511	515	mice	Species	10090
35088915	544	556	Gramcyclin A	Chemical	-
35088915	584	589	Abeta	Gene	11820
35088915	690	693	PS1	Gene	19164
35088915	698	702	mice	Species	10090
35088915	719	731	Gramcyclin A	Chemical	-
35088915	791	808	neuroinflammation	Disease	MESH:D000090862
35088915	835	838	PS1	Gene	19164
35088915	843	847	mice	Species	10090
35088915	859	871	Gramcyclin A	Chemical	-
35088915	903	910	glucose	Chemical	MESH:D005947
35088915	925	928	PS1	Gene	19164
35088915	933	937	mice	Species	10090
35088915	954	978	18-fluoro-2-deoxyglucose	Chemical	-
35088915	980	988	18 F-FDG	Chemical	MESH:D019788
35088915	1059	1071	Gramcyclin A	Chemical	-
35088915	1110	1133	glucagon-like peptide-1	Gene	14526
35088915	1135	1140	GLP-1	Gene	14526
35088915	1143	1149	GLP-1R	Gene	14652
35088915	1151	1213	proliferator-activated receptor gamma coactivator (PGC)-1alpha	Gene	19017
35088915	1218	1239	glucose transporter 4	Gene	20528
35088915	1241	1246	GLUT4	Gene	20528
35088915	1263	1287	insulin receptor (IRS)-1	Gene	16367
35088915	1359	1362	PS1	Gene	19164
35088915	1367	1371	mice	Species	10090
35088915	1387	1399	Gramcyclin A	Chemical	-
35088915	1437	1439	AD	Disease	MESH:D000544
35088915	1460	1465	GLP-1	Gene	14526
35088915	1476	1483	glucose	Chemical	MESH:D005947
35088915	1496	1501	DPP-4	Gene	13482
35088915	1512	1524	Gramcyclin A	Chemical	-
35088915	1567	1569	AD	Disease	MESH:D000544
35088915	Association	MESH:D000544	14526
35088915	Association	MESH:D003072	13482
35088915	Association	MESH:D005947	14526
35088915	Association	MESH:D005947	MESH:D000544
35088915	Association	MESH:D000544	13482
35088915	Association	MESH:D005947	MESH:D003072

